# PEI Transfection: Mechanisms, Protocols, and Troubleshooting

## Introduction to PEI Transfection

### What is PEI?

Polyethylenimine (PEI) is a synthetic cationic polymer composed of repeating ethylenimine units, each containing a protonatable amino group. It exists in two principal architectures: linear (L-PEI) and branched (B-PEI). The polymer's high density of primary, secondary, and tertiary amines gives it an exceptional buffering capacity across a wide pH range, a property that underpins its function as a transfection reagent. PEI complexes with negatively charged nucleic acids through electrostatic interactions, forming nanoparticles termed polyplexes that deliver genetic material into eukaryotic cells.

PEI transfection refers to the use of this polymer to introduce exogenous nucleic acids—typically plasmid DNA, but also siRNA, mRNA, or oligonucleotides—into cultured mammalian cells. The approach was first described in 1995 and has since become a mainstay of [molecular biology](/blog/careers/molecular-biology) laboratories due to its low cost, simplicity, and effectiveness across numerous cell lines. Unlike viral vectors, PEI does not integrate into the host genome, making it suitable for transient expression studies. Unlike liposomal reagents, PEI requires no complex lipid formulation and is stable at room temperature for extended periods.

### Why use PEI for transfection?

PEI offers several distinct advantages over alternative transfection methods. First, its cost per transfection is orders of magnitude lower than commercial lipofection reagents. A single gram of PEI powder, once dissolved and neutralized, can prepare thousands of transfection reactions. Second, PEI produces high transfection efficiencies in many commonly used cell lines, particularly HEK293 and its derivatives, which are widely employed for recombinant protein production and viral packaging. Third, PEI is compatible with serum-containing media, eliminating the need for media changes during the transfection procedure. Fourth, the reagent is chemically defined and batch-to-batch variability is minimal when sourced from reputable suppliers.

PEI is also versatile. It can be used for adherent and suspension cultures, for small-scale experiments in multiwell plates, and for large-scale transfections in bioreactors producing lentivirus or adeno-associated virus. For laboratories performing routine plasmid delivery, PEI represents a pragmatic balance of efficiency, cost, and simplicity. However, as with any transfection method, its performance is cell-type dependent, and optimization of key parameters is essential for reproducible success. Understanding the mechanistic basis of PEI-mediated delivery is the first step toward that optimization.

## Mechanism of PEI-Mediated Gene Delivery

### DNA-PEI polyplex formation

The transfection process begins when PEI and plasmid DNA are mixed in solution. Because PEI is positively charged at physiological pH and DNA is negatively charged due to its phosphate backbone, the two components spontaneously assemble into polyplexes. The driving force is entropic: counterion release from both polymers accompanies complex formation. The resulting particles are typically 50–200 nm in diameter, depending on the ratio of PEI nitrogen atoms to DNA phosphate groups—the N/P ratio.

At low N/P ratios, polyplexes carry a net negative or neutral surface charge, which promotes aggregation and reduces cellular uptake. At N/P ratios above 3, the polyplex surface is positively charged, facilitating electrostatic interaction with the negatively charged heparan sulfate proteoglycans on the cell membrane. This charge interaction triggers receptor-mediated endocytosis, predominantly via clathrin-coated pits, though macropinocytosis and caveolae-mediated pathways can also contribute depending on cell type and polyplex size.

The structure of the polyplex is not static. Once formed, polyplexes can aggregate in saline solutions, which is why PEI-DNA complexes are typically prepared in low-salt buffers or serum-free medium. The presence of serum proteins can also destabilize polyplexes by competing for surface charge, although PEI polyplexes are generally more serum-tolerant than lipoplexes.

### Endosomal escape and the proton sponge hypothesis

After internalization, polyplexes reside within endosomes that progressively acidify as they mature from early endosomes (pH ~6.0) to late endosomes and lysosomes (pH ~4.5–5.0). The proton sponge hypothesis, first proposed by Behr in 1997, explains how PEI escapes this degradative pathway. PEI contains a large fraction of secondary and tertiary amines with pKa values between 5 and 7. As the endosomal pH drops, these amines become protonated, consuming protons that would otherwise contribute to acidification. To maintain the pH gradient, the vacuolar ATPase pumps more protons into the endosome, accompanied by an influx of chloride ions and water. The resulting osmotic swelling increases endosomal volume and eventually ruptures the endosomal membrane, releasing the polyplex into the cytoplasm.

The proton sponge effect is not without controversy. Some studies suggest that membrane destabilization by direct interaction of PEI with the lipid bilayer, rather than osmotic lysis, is the primary escape mechanism. Regardless of the precise biophysical details, the functional consequence is clear: PEI polyplexes efficiently translocate from endosomes to the cytosol, avoiding lysosomal degradation that would otherwise destroy the nucleic acid cargo. This endosomal escape step is widely considered the rate-limiting barrier to successful transfection, and it explains why PEI's buffering capacity correlates with its transfection efficiency.

### Intracellular trafficking and nuclear entry

Once in the cytoplasm, the polyplex must deliver its DNA cargo to the nucleus for transcription to occur. The cytoplasm is a crowded, viscous environment, and naked DNA diffuses poorly. Polyplexes must therefore rely on active transport mechanisms. Microtubule-dependent motor proteins, particularly dynein, have been implicated in trafficking polyplexes toward the microtubule organizing center near the nucleus. This retrograde transport is thought to be facilitated by the polyplex's ability to recruit dynein through interactions with adaptor proteins.

Nuclear entry is the final barrier. For dividing cells, the breakdown of the nuclear envelope during mitosis provides a passive entry route, which is why PEI transfection efficiency is often higher in rapidly proliferating cells. In non-dividing cells, nuclear import requires passage through the nuclear pore complex, which restricts entry to particles smaller than approximately 40 kDa. PEI polyplexes are far larger than this limit, so nuclear entry in quiescent cells is inefficient. However, some PEI formulations include nuclear localization signals or are designed to release DNA near the nuclear periphery, where it may enter during transient envelope disruptions.

Once inside the nucleus, the plasmid DNA must be released from the polyplex. This dissociation is thought to occur through exchange with anionic nuclear components, such as chromatin and nucleic acids, which compete with PEI for DNA binding. The free plasmid then serves as a template for transcription, with transgene expression typically peaking 24–72 hours post-transfection.

## Key Factors Affecting PEI Transfection Efficiency

### N/P ratio and polyplex charge

The N/P ratio is the single most important parameter in PEI transfection. It is defined as the molar ratio of PEI nitrogen atoms to DNA phosphate groups. A ratio of 1:1 is the charge neutralization point. Below this, polyplexes are negatively charged and poorly internalized. Above this, polyplexes are positively charged and bind readily to cell surfaces.

For linear PEI (e.g., 25 kDa linear PEI from Polysciences, often referred to as PEI MAX), the optimal N/P ratio typically falls between 5 and 10. For branched PEI (25 kDa), ratios of 7–12 are commonly used. The optimal ratio depends on the cell line, the PEI preparation, and the DNA amount. Higher N/P ratios generally increase transfection efficiency up to a point, beyond which cytotoxicity becomes prohibitive. This is because free, uncomplexed PEI is toxic to cells, damaging the plasma membrane and mitochondria.

The N/P ratio also affects polyplex size and zeta potential. At optimal ratios, polyplexes are 100–150 nm in diameter with a positive zeta potential of +20 to +40 mV. These characteristics promote cellular uptake while minimizing aggregation. When optimizing PEI transfection for a new cell line, titrating the N/P ratio is the first and most impactful variable to test.

### PEI molecular weight and branching

PEI is available in a range of molecular weights, from 1.8 kDa to 800 kDa, and in linear or branched forms. The molecular weight and architecture profoundly influence transfection efficiency and toxicity. Low-molecular-weight PEI (<5 kDa) is less toxic but forms less stable polyplexes and escapes endosomes poorly. High-molecular-weight PEI (>50 kDa) is highly efficient but cytotoxic. The most widely used formulations are 25 kDa linear PEI and 25 kDa branched PEI.

Linear PEI generally outperforms branched PEI in terms of transfection efficiency and cell viability. This is attributed to its more efficient endosomal escape and reduced membrane disruption. Linear PEI also forms more compact polyplexes with a narrower size distribution. However, linear PEI is less soluble in water and must be dissolved in acidic solution before use. Branched PEI is easier to handle and is often preferred for siRNA delivery, where its higher charge density facilitates stable complex formation with short nucleic acids.

### Cell density and serum conditions

Cell density at the time of transfection significantly affects efficiency. Cells that are too sparse (<50% confluency) are more susceptible to PEI cytotoxicity and may not produce sufficient paracrine factors for robust growth. Cells that are too dense (>90% confluency) exhibit contact inhibition, reduced proliferation, and diminished uptake. For most adherent cell lines, 70–80% confluency at transfection is optimal.

Serum has a dual role in PEI transfection. On one hand, serum proteins can bind to polyplexes, reducing their effective charge and cellular uptake. On the other hand, serum protects cells from PEI-induced cytotoxicity and provides growth factors that maintain cell health. In practice, PEI transfection can be performed in serum-containing medium without a media change, which is a major practical advantage. However, for serum-sensitive cell lines or when maximum efficiency is required, transfecting in serum-free medium for 4–6 hours followed by replacement with complete medium is a common strategy.

## Standard PEI Transfection Protocol

### Materials and reagents

- Linear PEI 25 kDa (e.g., PEI MAX, Polysciences; or jetPEI, Polyplus)
- Plasmid DNA purified using a [Genejet Plasmid Miniprep Kit](/knowledge/molecular-biology/genejet-plasmid-miniprep-kit) or equivalent endotoxin-free preparation
- Serum-free medium (e.g., DMEM, Opti-MEM, or 150 mM NaCl)
- Complete growth medium appropriate for the cell line
- Sterile tubes and pipettes
- Hemocytometer or automated cell counter

Prepare a 1 mg/mL PEI stock solution by dissolving PEI powder in ultrapure water, adjusting the pH to 7.0 with HCl, and filter-sterilizing. This stock is stable at 4°C for months. For linear PEI, dissolve in water acidified to pH 2–3 with HCl, then neutralize.

### Step-by-step procedure

1. **Seed cells.** One day before transfection, seed cells in a 6-well plate at a density that will yield 70–80% confluency at the time of transfection. For HEK293 cells, this is typically 3–5 × 10⁵ cells per well. For HeLa cells, 2–3 × 10⁵ cells per well. Use complete growth medium without antibiotics, as antibiotics can interfere with polyplex formation and uptake.

2. **Prepare DNA solution.** For each well, dilute 1–2 µg of plasmid DNA in 100 µL of serum-free medium or 150 mM NaCl. Vortex briefly to mix.

3. **Prepare PEI solution.** For each well, dilute the appropriate volume of PEI stock in 100 µL of the same diluent. The volume is calculated based on the desired N/P ratio. For a 1:3 DNA-to-PEI mass ratio (which corresponds to an N/P ratio of approximately 6–7 for 25 kDa linear PEI), use 3 µL of 1 mg/mL PEI per 1 µg of DNA.

4. **Form polyplexes.** Add the PEI solution dropwise to the DNA solution. Vortex immediately for 3–5 seconds. Do not reverse the order of addition, as this affects polyplex uniformity.

5. **Incubate.** Allow the mixture to stand at room temperature for 15–30 minutes. Do not exceed 30 minutes, as prolonged incubation can lead to polyplex aggregation and reduced activity.

6. **Add to cells.** Add the polyplex mixture dropwise to the cells, distributing it evenly across the well. Gently swirl the plate to mix.

7. **Incubate.** Return the cells to the incubator. Do not change the medium unless the cell line is particularly sensitive to PEI toxicity. For most cell lines, the polyplexes can remain on the cells for the duration of the experiment.

8. **Assay.** Analyze transgene expression 24–72 hours post-transfection, depending on the experimental readout. For fluorescent reporters, visualize by microscopy or quantify by flow cytometry. For secreted proteins, assay the conditioned medium.

### Optimization of DNA and PEI amounts

The protocol above provides a starting point, but optimization is almost always required for a new cell line or application. A typical optimization matrix involves titrating DNA amount (0.5, 1, 2, 4 µg per well of a 6-well plate) against DNA-to-PEI mass ratios (1:2, 1:3, 1:4, 1:5). Transfection efficiency is assessed by flow cytometry for fluorescent reporters, and cell viability is assessed by a metabolic assay such as MTT or resazurin reduction. The optimal condition is the one that maximizes the product of efficiency and viability.

For high-throughput optimization, consider using a 96-well plate format with scaled-down volumes (20 µL total polyplex volume per well). This approach allows rapid screening of multiple conditions with minimal reagent consumption. [Serial dilution](/knowledge/molecular-biology/serial-dilution) techniques can be applied to generate precise DNA and PEI concentration gradients.

## Optimization Strategies for PEI Transfection

### Titrating DNA and PEI concentrations

The DNA amount per cell is a critical determinant of transfection outcome. Too little DNA yields low expression; too much DNA can saturate the cellular machinery and increase toxicity. For most adherent cell lines, 1–2 µg of plasmid DNA per 10⁶ cells is a reasonable starting range. For suspension cultures, the optimal amount may be higher due to reduced cell surface area available for polyplex binding.

The DNA-to-PEI mass ratio is the primary variable for controlling polyplex charge and stability. Ratios of 1:2 to 1:4 (DNA:PEI) are typical for linear PEI. Below 1:2, polyplexes may be insufficiently charged for efficient uptake. Above 1:4, free PEI in solution increases cytotoxicity. The optimal ratio should be determined empirically for each cell line and PEI batch.

### Adjusting cell confluency and incubation time

Cell confluency at transfection should be optimized alongside the DNA and PEI concentrations. For rapidly dividing cells like HEK293, 70–80% confluency is ideal. For slower-growing cells, such as primary fibroblasts, a higher confluency (80–90%) may be necessary to ensure sufficient cell numbers. Conversely, for cells that are sensitive to contact inhibition, lower confluency (50–60%) may improve uptake.

The incubation time with polyplexes can also be varied. Standard protocols leave polyplexes on cells indefinitely. However, for sensitive cell lines, replacing the medium 4–6 hours post-transfection can reduce cytotoxicity without substantially compromising efficiency. For maximum efficiency, some protocols recommend a "shock" treatment with 10% DMSO for 2–5 minutes at 4 hours post-transfection, which is thought to enhance endosomal escape.

### Using enhancers or additives

Several additives can improve PEI transfection efficiency. Chloroquine, a lysosomotropic agent, can enhance endosomal escape by further buffering endosomal pH, but it is toxic and must be removed after 4–6 hours. Calcium phosphate, when co-precipitated with DNA and PEI, can improve transfection in some cell lines by promoting endocytosis. Glycerol (15% v/v) added for 2–4 minutes at 4 hours post-transfection can permeabilize cell membranes and enhance polyplex entry.

For siRNA delivery, PEI can be formulated with targeting ligands, such as transferrin or antibodies, to improve cell-type specificity. For in vivo applications, PEGylation of PEI (conjugation with polyethylene glycol) reduces serum protein binding and prolongs circulation time, though it also reduces transfection efficiency.

## PEI Transfection in Different Cell Types

### Adherent vs. suspension cells

PEI transfection works well for both adherent and suspension cultures, but the protocols differ. Adherent cells are typically transfected at 70–80% confluency in multiwell plates. Suspension cells, such as HEK293 suspension variants or CHO cells grown in spinner flasks, require higher DNA and PEI amounts per cell because the polyplexes must collide with cells in three-dimensional culture. For suspension cultures, cells are typically pelleted and resuspended in fresh medium before transfection, and the polyplex mixture is added with gentle agitation.

For large-scale production of [lentiviral vectors](/knowledge/molecular-biology/lentiviral-vector), HEK293T cells in suspension are commonly transfected with PEI using a three-plasmid system (packaging plasmid, envelope plasmid, and transfer vector). This approach routinely achieves viral titers sufficient for most applications. The key to success in suspension is maintaining high cell viability (>90%) and using a PEI formulation optimized for low toxicity, such as linear PEI MAX.

### Hard-to-transfect cells and alternatives

PEI is not universally effective. Many primary cells, stem cells, and suspension lymphocytes are refractory to PEI transfection due to low endocytic activity, high nuclease expression, or inefficient nuclear import. For these cells, alternative methods such as electroporation or lentiviral transduction are often more reliable. When PEI is the only option, optimization is critical: lower N/P ratios, reduced DNA amounts, and extended incubation times may improve outcomes, albeit with reduced efficiency.

For [siRNA transfection](/knowledge/molecular-biology/sirna-transfection), PEI is generally less effective than lipid-based reagents. The short, rigid duplex structure of siRNA forms less stable complexes with PEI, and the endosomal escape efficiency required for functional delivery is higher. If siRNA delivery is the goal, consider [siRNA Transfection](/knowledge/molecular-biology/sirna-transfection) with dedicated lipid reagents. For gene delivery to hard-to-transfect cells, [Cell Transfection](/knowledge/molecular-biology/cell-transfection) provides an overview of alternative strategies.

## Troubleshooting Common PEI Transfection Problems

### Low transfection efficiency

Low efficiency is the most common complaint. Begin by verifying that the plasmid DNA is of high quality. DNA contaminated with endotoxin, protein, or RNA can inhibit polyplex formation. Use an endotoxin-free plasmid purification kit and measure the A260/A280 ratio (should be 1.8–2.0). Confirm the DNA is supercoiled by agarose gel electrophoresis; nicked or linearized DNA transfects less efficiently.

Next, check the N/P ratio. If efficiency is low and toxicity is minimal, increase the DNA-to-PEI ratio. If efficiency is low and toxicity is high, decrease the ratio. Also verify that the PEI stock solution is properly prepared. Linear PEI must be fully dissolved and neutralized; incomplete dissolution results in variable activity.

Cell health is another critical factor. Cells that are stressed, contaminated with mycoplasma, or passaged excessively (>30 passages) transfect poorly. Use low-passage cells and maintain them in logarithmic growth. Finally, confirm that the transfection is performed in the absence of antibiotics, which can interfere with polyplex uptake.

### Cytotoxicity and cell death

PEI cytotoxicity is dose-dependent and primarily caused by free polymer. If cells are dying within 24 hours of transfection, reduce the PEI amount or the N/P ratio. Alternatively, reduce the DNA amount, as higher DNA concentrations require proportionally more PEI. For sensitive cell lines, replace the medium 4–6 hours post-transfection to remove excess polyplexes and free PEI.

Another strategy is to switch from branched to linear PEI, which is generally less toxic. Using a lower-molecular-weight PEI (e.g., 10 kDa) can also reduce toxicity, though efficiency may decrease. Finally, ensure that the polyplex mixture is not left at room temperature for more than 30 minutes before addition to cells, as aggregated polyplexes are more cytotoxic.

### Poor reproducibility

Inconsistent results between experiments are often traced to variability in cell density, PEI stock preparation, or polyplex formation conditions. Standardize the cell seeding density and passage number. Prepare a large batch of PEI stock solution and aliquot it for single-use storage at −20°C to avoid repeated freeze-thaw cycles. Use the same batch of plasmid DNA for all replicates.

Polyplex formation is sensitive to the order and speed of mixing. Always add PEI to DNA, not the reverse, and vortex immediately. Use the same incubation time (15–30 minutes) for all samples. Finally, ensure that the serum-free medium or NaCl solution used for polyplex formation is from the same batch and at the same temperature. Small variations in ionic strength can significantly affect polyplex size and charge.

## Comparison with Other Transfection Methods

### PEI vs. Lipofectamine

Lipofectamine and other lipid-based reagents are the primary commercial alternatives to PEI. Lipofectamine 2000 and 3000 are cationic lipid formulations that form lipoplexes with DNA. They generally achieve higher transfection efficiencies than PEI in many cell lines, particularly those that are difficult to transfect. However, they are significantly more expensive, are sensitive to serum, and require media changes after transfection.

For routine transfection of HEK293, HeLa, and CHO cells, PEI is often preferred due to its cost advantage and serum compatibility. For primary cells, stem cells, and neurons, Lipofectamine is usually more effective. The choice ultimately depends on the cell type, the required efficiency, and the budget. For applications where cost is a primary concern and the cell line is PEI-permissive, PEI is the rational choice.

### PEI vs. electroporation

Electroporation uses brief electrical pulses to create transient pores in the cell membrane, allowing DNA to enter directly. It is highly effective for hard-to-transfect cells, including primary lymphocytes and stem cells, and can achieve efficiencies exceeding 90%. However, electroporation requires specialized equipment, is associated with significant cell death (typically 20–50%), and is difficult to scale for large numbers of cells.

PEI is gentler, cheaper, and easier to scale, but its efficiency is lower in challenging cell types. For experiments requiring high efficiency in difficult cells, electroporation is the method of choice. For routine plasmid delivery in standard cell lines, PEI is more practical. The choice depends on whether efficiency or convenience is the priority.

### When to choose PEI

PEI is the preferred method when: (1) cost is a significant factor, (2) the cell line is known to be PEI-permissive (e.g., HEK293, HeLa, CHO), (3) serum-containing medium is required, (4) large-scale transfection is needed (e.g., virus production), or (5) transient expression is sufficient. PEI is not recommended for: (1) primary cells or stem cells, (2) siRNA delivery, (3) experiments requiring stable integration, or (4) in vivo applications without extensive formulation modification.

For [stable cell line generation](/knowledge/molecular-biology/stable-cell-line-generation), PEI can be used, but the efficiency of integration is low, and antibiotic selection is required. For in vivo gene delivery, PEI formulations with targeting ligands or PEGylation have been developed, but they remain experimental. In such cases, viral vectors are the standard approach.

## Safety and Best Practices for PEI Handling

### Handling and storage

PEI is a cationic polymer that can irritate skin, eyes, and mucous membranes. Wear gloves, safety glasses, and a lab coat when handling the powder or concentrated solutions. Weigh PEI powder in a fume hood to avoid inhalation. PEI solutions are stable at 4°C for months when protected from light. For long-term storage, aliquot and freeze at −20°C; avoid repeated freeze-thaw cycles, which can cause polymer degradation.

Polyplexes should be prepared in a biosafety cabinet to maintain sterility. Dispose of pipette tips and tubes that contact PEI or polyplexes in the appropriate solid waste containers. PEI is not classified as hazardous waste, but it should not be discharged into the environment. Follow your institution's guidelines for chemical disposal. For general laboratory safety practices, refer to your institution's [Lab Safety](/knowledge/molecular-biology/lab-safety) guidelines.

### Waste disposal

Liquid waste containing PEI or polyplexes can be inactivated by adding bleach to a final concentration of 10% v/v and allowing it to stand for 30 minutes before disposal down the sink. Solid waste, such as contaminated tips and tubes, should be placed in biohazard waste containers if they have contacted cells, or in regular laboratory waste if they have only contacted PEI solutions. Always consult your institution's environmental health and safety office for specific disposal requirements.

## Common Pitfalls

Several recurring mistakes undermine PEI transfection experiments. The first is using poor-quality plasmid DNA. Endotoxin contamination is a frequent culprit, as endotoxin activates Toll-like receptor 4 on cells, triggering an inflammatory response that reduces transfection efficiency and cell viability. Always use endotoxin-free plasmid purification kits.

The second pitfall is improper PEI stock preparation. Linear PEI is notoriously difficult to dissolve. If the solution is cloudy or contains particulates, it has not fully dissolved, and transfection efficiency will be inconsistent. Heat the solution to 80°C for 10 minutes to facilitate dissolution, then cool to room temperature before use.

The third pitfall is neglecting to optimize for the specific cell line. A protocol that works beautifully for HEK293 may fail entirely for HeLa or CHO cells. Always perform a titration experiment when establishing PEI transfection in a new cell line.

The fourth pitfall is using cells that are too confluent or too sparse. Both conditions reduce efficiency. Standardize seeding density and verify confluency before transfection.

The fifth pitfall is adding polyplexes to cells in medium containing antibiotics. Penicillin and streptomycin can interfere with polyplex uptake and reduce efficiency. Remove antibiotics from the medium at least one passage before transfection.

Finally, be aware that PEI transfection efficiency decreases with increasing plasmid size. Plasmids larger than 10 kb transfect poorly. If your construct is large, consider using a smaller vector or an alternative delivery method.

## Frequently Asked Questions

### What is the mechanism of PEI transfection?

PEI transfection proceeds through four steps: (1) electrostatic complexation of positively charged PEI with negatively charged DNA to form polyplexes; (2) cellular uptake via endocytosis, primarily clathrin-mediated; (3) endosomal escape through the proton sponge effect, where PEI's buffering capacity causes osmotic swelling and endosomal rupture; and (4) nuclear delivery, either passively during mitosis or actively through nuclear pore complexes. Once in the nucleus, the DNA is released and transcribed.

### How do I perform a PEI transfection protocol?

A standard protocol involves: (1) seeding cells to 70–80% confluency one day prior; (2) diluting 1–2 µg of plasmid DNA in 100 µL of serum-free medium; (3) diluting PEI at a 1:3 DNA-to-PEI mass ratio in 100 µL of the same medium; (4) adding PEI to DNA, vortexing, and incubating for 15–30 minutes; (5) adding the polyplex mixture dropwise to cells; and (6) assaying 24–72 hours later. Optimization of DNA amount and N/P ratio is recommended for each cell line.

### What is the optimal N/P ratio for PEI transfection?

The optimal N/P ratio is typically 5–10 for linear PEI and 7–12 for branched PEI. This corresponds to a DNA-to-PEI mass ratio of approximately 1:2 to 1:4 for 25 kDa linear PEI. The exact optimum depends on the cell line, PEI molecular weight, and DNA amount. Titration experiments are essential to determine the optimal ratio for a specific application.

### Why is my PEI transfection efficiency low?

Low efficiency can result from poor DNA quality, suboptimal N/P ratio, improper PEI stock preparation, unhealthy or over-passaged cells, excessive cell confluency, or the presence of antibiotics in the medium. Troubleshoot systematically by verifying DNA quality, performing a titration of DNA and PEI concentrations, and confirming cell health and confluency.

### How can I reduce PEI cytotoxicity?

Reduce the PEI amount or N/P ratio, switch from branched to linear PEI, use a lower-molecular-weight PEI, replace the medium 4–6 hours post-transfection, or reduce the DNA amount. Ensuring that polyplexes are freshly prepared and not aggregated also reduces toxicity.

### Can PEI be used for in vivo transfection?

Yes, but with limitations. Unmodified PEI is rapidly cleared from circulation and can be toxic at effective doses. For in vivo applications, PEI is often PEGylated to reduce serum protein binding and prolong circulation, or conjugated with targeting ligands for cell-type specificity. These formulations remain largely experimental, and viral vectors are generally preferred for in vivo gene delivery.

### What is the difference between linear and branched PEI for transfection?

Linear PEI (25 kDa) is generally more efficient and less toxic than branched PEI (25 kDa). It forms more compact polyplexes and escapes endosomes more effectively. However, linear PEI is harder to dissolve and requires acidified water for stock preparation. Branched PEI is easier to handle and is sometimes preferred for siRNA delivery due to its higher charge density. For most plasmid DNA transfections, linear PEI is the better choice.

## Key Takeaways

- PEI transfection is a cost-effective, serum-compatible method for delivering plasmid DNA to mammalian cells, particularly HEK293, HeLa, and CHO lines.
- The mechanism involves polyplex formation, endocytosis, proton sponge-mediated endosomal escape, and nuclear delivery during mitosis.
- The N/P ratio is the most critical parameter; optimal ratios are typically 5–10 for linear PEI and 7–12 for branched PEI.
- Linear 25 kDa PEI is preferred over branched PEI for most applications due to higher efficiency and lower toxicity.
- Optimization of DNA amount, PEI concentration, cell density, and incubation time is essential for each cell line.
- Common pitfalls include poor DNA quality, improper PEI dissolution, excessive cell confluency, and antibiotic interference.
- PEI is not suitable for all cell types; primary cells and stem cells may require electroporation or lipid-based reagents.
- Always prepare polyplexes fresh, add PEI to DNA, and incubate for no more than 30 minutes before adding to cells.

## Further Reading

- Zhou X et al. *PEI, a new transfection method, augments the inhibitory effect of RBM5 on prostate cancer*. Biochemical and biophysical research communications. 2024. [PubMed 38402723](https://doi.org/10.1016/j.bbrc.2024.149703)
- Hu Y et al. *Liter-scale manufacturing of shelf-stable plasmid DNA/PEI transfection particles for viral vector production*. [Molecular therapy](/blog/guides/molecular-therapy). Methods & clinical development. 2024. [PubMed 38352269](https://doi.org/10.1016/j.omtm.2024.101194)
- Yang S et al. *Plate centrifugation enhances the efficiency of polyethylenimine-based transfection and lentiviral infection*. Journal of virological methods. 2024. [PubMed 39357745](https://doi.org/10.1016/j.jviromet.2024.115039)
- Trivedi PD et al. *Comparison of highly pure rAAV9 vector stocks produced in suspension by PEI transfection or HSV infection reveals striking quantitative and qualitative differences*. [Molecular therapy](/blog/guides/molecular-therapy). Methods & clinical development. 2022. [PubMed 35071688](https://doi.org/10.1016/j.omtm.2021.12.006)
- Elshereef AA et al. *High cell density transient transfection of CHO cells for TGF-β1 expression*. Engineering in life sciences. 2019. [PubMed 32624966](https://doi.org/10.1002/elsc.201800174)
- Cui P et al. *Small Molecule Modifications Significantly Increase the Transfection Efficiency of Low-Molecular Polymer*. Journal of biomedical nanotechnology. 2022. [PubMed 35484748](https://doi.org/10.1166/jbn.2022.3252)



<div data-calculator="toxicity"></div>

## Related Clinical & Scientific Guides

* [MAPK Pathway: Mechanism, Function, and Clinical Relevance](/knowledge/molecular-biology/mapk-pathway)
* [Mammalian Cell Culture Bioreactors: A Practical Guide](/knowledge/molecular-biology/mammalian-cell-culture-bioreactor)
* [Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks](/knowledge/molecular-biology/nucleotide-formation)